About Miltenyi Biotec
Miltenyi Biotec is a Healthcare company based in Bergisch Gladbach (Germany) founded in 1989 by Stefan Miltenyi. It develops tools and products for research and clinical application. The company has 585 employees. Miltenyi Biotec has completed 3 acquisitions, including LaVision BioTec, Lentigen and lino Biotech. Its chief executive, as recorded, is Boris Stoffel. Its website miltenyibiotec.com draws about 193 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
Founded in 1989 and headquartered in Bergisch Gladbach, Germany, the company operates in the biomedical research and cellular therapy sector. Products are provided for cell isolation, flow cytometry, sample preparation, cell culture, molecular analysis, clinical applications, and imaging. Expertise is maintained in immunology, stem cell biology, neuroscience, cancer research, hematology, graft engineering, and apheresis.
- Headquarters Bergisch Gladbach, Germany
- Employees 585
- Founders Stefan Miltenyi
- SectorsHealthcare
- Website miltenyibiotec.com
- Social LinkedIn X Facebook
- Latest Funding Round$304.41K (USD), Grant
Mar 2021
- InvestorsHHS
& 1 more
- Employee Count585
- Investments & AcquisitionsLaVision BioTec
& 2 more
Funding Insights of Miltenyi Biotec
- Total Rounds 18
- Last Round Grant — $304,414
- Investors Count 2
Latest 10 of 18 funding rounds of Miltenyi Biotec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $304,414 | Grant | – | – | |
| Jan 2021 | $821,672 | Grant | – | – | |
| Jan 2020 | $539,066 | Grant | – | – | |
| Jun 2019 | $283,084 | Grant | – | – | |
| Mar 2019 | $7,173 | Grant | – | – | |
| Jan 2019 | Grant | – | – | ||
| Dec 2018 | $286,131 | Grant | – | – | |
| Jun 2018 | $290,785 | Grant | – | – | |
| Jan 2018 | $308,425 | Grant | – | – | |
| Jan 2018 | $299,863 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Miltenyi Biotec
Miltenyi Biotec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Miltenyi Biotec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Miltenyi Biotec
2 people are tracked at Miltenyi Biotec (2 in leadership); the tracked headcount is 585.
| Name | Role | Group |
|---|---|---|
Stefan Miltenyi | Founder & MD | Leadership |
Boris Stoffel | CEO | Leadership |
Complete people profiles for Miltenyi Biotec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Miltenyi Biotec
Miltenyi Biotec has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include LaVision BioTec, Lentigen and lino Biotech.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Molecular interactions in biological samples are measured via focal molography. | lino-biotech.com | Zurich, Switzerland | 2020 | Feb 2023 | •••• | |
Microscopes for cell analysis and preclinical imaging are developed. | lavisionbiotec.com | Bielefeld, Germany | 2000 | Oct 2018 | •••• | |
Lentiviral vectors are developed for pre-clinical and clinical applications. | lentigen.com | Gaithersburg, United States | 2004 | Aug 2014 | •••• |
Complete acquisition details for Miltenyi Biotec
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Miltenyi Biotec
6 dated milestones of Miltenyi Biotec across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Miltenyi Biotec is founded.
- Funding First funding round.
- Acquisition Acquires Lentigen.
- Acquisition Acquires LaVision BioTec.
- Funding Latest funding round, Grant, of $304K.
- Acquisition Acquires lino Biotech.
Web traffic of Miltenyi Biotec
The website of Miltenyi Biotec (miltenyibiotec.com) receives about 192.6K visits a month.
- Monthly visits192.6K
▼ 7.5% vs previous month
Websites whose visitors overlap most with Miltenyi Biotec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biolegend.com | 100% | 229.6K | #142,656 | View details | |
| stemcell.com | 92% | 262.4K | #179,047 | View details | |
| bdbiosciences.com | 88% | 331.8K | #154,504 | View details | |
| rndsystems.com | 75% | 349K | #159,292 | View details | |
| trevigen.com | 70% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Miltenyi Biotec
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Miltenyi Biotec
Complete news archive for Miltenyi Biotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Miltenyi Biotec
Miltenyi Biotec was founded in 1989 and raised its 1st funding round 21 years after it was founded.
Miltenyi Biotec is headquartered in Bergisch Gladbach, Germany. It is registered at Bergisch Gladbach, North Rhine-westphalia, Germany.
Boris Stoffel is the CEO of Miltenyi Biotec, as recorded in our data.
Miltenyi Biotec has 585 employees.
Founded in 1989 and headquartered in Bergisch Gladbach, Germany, the company operates in the biomedical research and cellular therapy sector. Products are provided for cell isolation, flow cytometry, sample preparation, cell culture, molecular analysis, clinical applications, and imaging. Expertise is maintained in immunology, stem cell biology, neuroscience, cancer research, hematology, graft engineering, and apheresis.
Miltenyi Biotec has made 3 acquisitions, including LaVision BioTec, Lentigen, and lino Biotech.
Miltenyi Biotec has 2 investors. Key investors include HHS, and European Union.
The website of Miltenyi Biotec receives about 193 thousand visits a month.